NCT06195943
- Conditions
- Behavior, Digestive System Diseases, Exercise, +7 more
- Locations
-
- Penn State Hershey Medical Center Hershey, Pennsylvania, United States
Clinical trial condition
NASH
Explore clinical trials studying NASH. Study availability and eligibility vary by location and protocol.
42 public trials
11 recruiting studies
NASH trial results
NCT04006145
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
- Locations
-
- Hope Clinical Research Canoga Park, California, United States
- Inland Empire Clinical Trials, LLC Rialto, California, United States
- Peak Gastroenterology Associates Colorado Springs, Colorado, United States
- Integrity Clinical Research, LLC Doral, Florida, United States
NCT04232293
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +12 more
- Locations
-
- CHU d'Angers Angers, France
- CHU de Nantes Nantes, France
NCT05560607
- Conditions
- Digestive System Diseases, Fatty Liver, Fatty Liver, Nonalcoholic, +7 more
- Locations
-
- Research Site San Antonio, Texas, United States
NCT05203237
- Conditions
- Body Weight, Body Weight Changes, NASH, +3 more
- Locations
-
- Viking Clinical Site Adelaide, South Australia, Australia
NCT06342947
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +5 more
- Locations
-
- Aligos Clinical Study Site 18 Chandler, Arizona, United States
- Aligos Clinical Study Site 15 Peoria, Arizona, United States
- Aligos Clinical Study Site 17 Tucson, Arizona, United States
- Aligos Clinical Study Site 35 Chula Vista, California, United States
NCT06491576
- Conditions
- NASH
- Locations
-
- The First Bethune Hospital of Jilin University Changchun, Jilin, China
NCT05193916
- Conditions
- NASH
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Beijing Youan Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- The First Hospital of Lanzhou University Lanzhou, Gansu, China
Completed
Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes
NCT06348706
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Nancy Elbarbary Cairo, Egypt
NCT04048135
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
- Locations
-
- 89bio Clinical Study Site Madison, Alabama, United States
- 89bio Clinical Study Site Chandler, Arizona, United States
- 89bio Clinical Study Site Tucson, Arizona, United States
- 89bio Clinical Study Site Chula Vista, California, United States